Titan Biotech Limited reported unaudited earnings results for the third quarter and nine months ended December 31, 2013. For the quarter, the company reported total income from operations of INR 93.318 million compared to INR 67.884 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 6.320 million compared to INR 5.273 million a year ago. Profit before tax was INR 5.877 million compared to INR 4.079 million a year ago. Net profit was INR 3.881 million compared to INR 2.568 million a year ago. Basic and diluted earnings per share after extraordinary items was INR 0.58 compared to INR 0.38 a year ago.

For the nine months, the company reported total income from operations of INR 280.124 million compared to INR 196.151 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 15.315 million compared to INR 15.318 million a year ago. Profit before tax was INR 17.229 million compared to INR 14.792 million a year ago. Net profit was INR 11.373 million compared to INR 9.911 million a year ago. Basic and diluted earnings per share before and after extraordinary items were INR 1.80 compared to INR 1.41 a year ago.